Clinical analysis of speculum-based vaginal packing for high-dose-rate intracavitary tandem and ovoid brachytherapy in cervical cancer

被引:6
作者
Sud, Shivani [1 ]
Roth, Toni [2 ]
Jones, Ellen [3 ]
机构
[1] Univ N Carolina, Sch Med, Chapel Hill, NC USA
[2] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA
[3] Univ North Carolina Chapel Hill, Dept Radiat Oncol, Chapel Hill, NC USA
关键词
intracavitary brachytherapy; cervical cancer; rectal dose; bladder dose; speculum; retractor; LATE RECTAL COMPLICATIONS; VOLUME PARAMETERS; SPACER BALLOON; CARCINOMA; REDUCTION; RECOMMENDATIONS; RADIOTHERAPY; RETRACTOR; CISPLATIN; TERMS;
D O I
10.5114/jcb.2018.74316
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Intra-vaginal packing is used to fix the applicator and displace organs at risk (OAR) during high-doserate intracavitary tandem and ovoid brachytherapy (HDR-ICB). We retain the speculum from applicator placement as a dual-function bladder and rectum retractor during treatment. Our objective is to review salient techniques for OAR displacement, share our packing technique, and determine the reduction in dose to OAR and inter-fraction variability of dose to OAR, associated with speculum-based vaginal packing (SBVP) in comparison to conventional gauze packing during HDR-ICB. Material and methods: We reviewed HDR-ICB treatment plans for 45 patients, including 10 who underwent both conventional gauze packing and SBVP. Due to institutional inter-provider practice differences, patients non-selectively received either packing procedure. Packing was performed under conscious sedation, followed by cone beam computed tomography used for dosimetric planning. Maximum absolute and percent-of-prescription dose to the International Commission of Radiation Units bladder and rectal points in addition to D-0.1cc, D-1.0cc, and D-2.0cc volumes of the bladder and rectum were analyzed and compared for each packing method using an independent sample t-test. Results: Of the 179 fractions included, 73% and 27% used SBVP and gauze packing, respectively. For patients prescribed 6 Gy to point A, SBVP was associated with reduced mean D-0.1cc bladder dose, inter-fraction variability in D-0.1cc bladder dose by 9.3% (p = 0.026) and 9.0%, respectively, and statistically equivalent rectal D-0.1cc, D-1.0cc, and D-2.0cc. Patients prescribed 5.5 Gy or 5 Gy to point A after dose optimization, were less likely to benefit from SBVP. In the intra- patient comparison, 80% of patients had reduction in at least one rectum or bladder parameter. Conclusions: In patients with conducive anatomy, SBVP is a cost-efficient packing method that is associated with improved bladder sparing and comparable rectal sparing relative to gauze packing during HDR-ICB without general anesthesia.
引用
收藏
页码:32 / 39
页数:8
相关论文
共 50 条
  • [21] PHYSICS CONTRIBUTIONS AND CLINICAL OUTCOME WITH 3D-MRI-BASED PULSED-DOSE-RATE INTRACAVITARY BRACHYTHERAPY IN CERVICAL CANCER PATIENTS
    Chargari, Cyrus
    Magne, Nicolas
    Dumas, Isabelle
    Messai, Taha
    Vicenzi, Lisa
    Gillion, Norman
    Morice, Philippe
    Haie-Meder, Christine
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (01): : 133 - 139
  • [22] Clinical transition to model-based dose calculation algorithm: A retrospective analysis of high-dose-rate tandem and ring brachytherapy of the cervix
    Jacob, Dayee
    Lamberto, Melissa
    Lawrence, Lana DeSouza
    Mourtada, Firas
    BRACHYTHERAPY, 2017, 16 (03) : 624 - 629
  • [23] Comparison of Vaginal Dosimetry Between Tandem Ovoid (TO) and Tandem Ring (TR) Applicator in CT-Based High Dose Rate Intracavitary Brachytherapy of Cervix
    Ramya Rangarajan
    S. Saravanan
    Indian Journal of Gynecologic Oncology, 2022, 20
  • [24] Low-Dose-Rate versus High-Dose-Rate intracavitary brachytherapy in cervical cancer - Final Results of a Phase III randomized trial
    Mahantshetty, Umesh
    Lewis, Shirley
    Engineer, Reena
    Swamidas, Jamema
    Chopra, Supriya
    Gurram, Lavanya
    Kinhikar, Rajesh
    Deshpande, Deepak
    Kirisits, Christian
    Shrivastava, Shyamkishore
    BRACHYTHERAPY, 2021, 20 (06) : 1146 - 1155
  • [25] Biological effective doses in the intracavitary high dose rate brachytherapy of cervical cancer
    Sharma, B. Arunkumar
    Singh, Th. Tomcha
    Singh, L. Jaichand
    Singh, Y. Indibor
    Devi, Y. Sobita
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2011, 3 (04) : 188 - 192
  • [26] Combined Interstitial and Intracavitary High-Dose Rate Brachytherapy of Cervical Cancer
    Itami, Jun
    Murakami, Naoya
    Watanabe, Miho
    Sekii, Shuhei
    Kasamatsu, Takahiro
    Kato, Shingo
    Hirowatari, Hisako
    Ikushima, Hitoshi
    Ando, Ken
    Ohno, Tatsuya
    Okamoto, Hiroyuki
    Okuma, Kae
    Igaki, Hiroshi
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [27] Dose to pelvic lymph nodes in locally advanced cervical cancer during high-dose-rate brachytherapy with tandem-ring applicators
    Moghani, Mona Malekzadeh
    Siavashpour, Zahra
    Ogorodniitchouk, Oleksander
    Moreno-Acosta, Pablo
    Plattard, Delphine
    Vallard, Alexis
    Sotton, Sandrine
    Bouleftour, Wafa
    Langrand-Escure, Julien
    Magne, Nicolas
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2022, 14 (02) : 183 - 188
  • [28] Freiburg flap used as vaginal applicator with/without free-hand interstitial needles in three-dimensional high-dose-rate brachytherapy for vaginal stump recurrence of cervical cancer
    He, Mingyuan
    Zhao, Hongfu
    Zhang, Yuqing
    Zhang, Ning
    Zhao, Zhipeng
    Cheng, Guanghui
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2024, 16 (05) : 344 - 351
  • [29] FACTORS FOR PREDICTING RECTAL DOSE OF HIGH-DOSE-RATE INTRACAVITARY BRACHYTHERAPY AFTER PELVIC IRRADIATION IN PATIENTS WITH CERVICAL CANCER: A RETROSPECTIVE STUDY WITH RADIOGRAPHY-BASED DOSIMETRY
    Huang, Eng-Yen
    Wang, Chong-Jong
    Lan, Jen-Hong
    Chen, Hui-Chun
    Fang, Fu-Min
    Hsu, Hsuan-Chih
    Huang, Yu-Jie
    Wang, Chang-Yu
    Wang, Yu-Ming
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (02): : 490 - 495
  • [30] Urethral dosimetry and toxicity with high-dose-rate interstitial brachytherapy for vaginal cancer
    Rajagopalan, Malolan S.
    Kannan, Neeta
    Kim, Hayeon
    Houser, Christopher J.
    Beriwal, Sushil
    BRACHYTHERAPY, 2013, 12 (03) : 248 - 253